Virtu Financial LLC Biogen Inc. Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

A detailed history of Virtu Financial LLC transactions in Biogen Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 21,207 shares of BIIB stock, worth $3.11 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

21,207

Holding current value

$3.11 Million

% of portfolio

0.23%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	BUY	$189.07 - $236.8 $4.01 Million - $5.02 Million	21,207 New	21,207 $4.11 Million
Q1 2024 May 20, 2024	BUY	$212.02 - $267.71 $2.8 Million - $3.53 Million	13,200 New	13,200 $2.85 Million
Q2 2023 Jul 27, 2023	BUY	$275.25 - $318.06 $2.69 Million - $3.11 Million	9,785 New	9,785 $2.79 Million
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $626,758 - $745,332	3,342 Added 97.92%	6,755 $1.38 Million
Q1 2022 May 17, 2022	SELL	$193.77 - $244.14 $764,422 - $963,132	-3,945 Reduced 53.62%	3,413 $719,000
Q4 2021 Feb 17, 2022	SELL	$223.92 - $287.77 $346,180 - $444,892	-1,546 Reduced 17.36%	7,358 $1.77 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $2.13 Million - $2.78 Million	-7,522 Reduced 45.79%	8,904 $2.52 Million
Q2 2021 Sep 17, 2021	BUY	$259.0 - $414.71 $4.25 Million - $6.81 Million	16,426 New	16,426 $5.69 Million
Q3 2020 Dec 11, 2020	SELL	$264.77 - $305.71 $2.28 Million - $2.63 Million	-8,602 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $2.22 Million - $2.95 Million	8,602 New	8,602 $2.3 Million
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $520,221 - $718,821	-2,364 Closed	0 $0
Q3 2019 Nov 20, 2019	SELL	$217.44 - $243.88 $2.31 Million - $2.59 Million	-10,601 Reduced 81.77%	2,364 $550,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $4.73 Million - $5.21 Million	-21,574 Reduced 62.46%	12,965 $3.03 Million
Q1 2019 Apr 12, 2019	BUY	$216.71 - $338.96 $7.27 Million - $11.4 Million	33,534 Added 3336.72%	34,539 $8.16 Million
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $1.07 Million - $1.35 Million	-3,841 Reduced 79.26%	1,005 $302,000
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.22 Million - $1.59 Million	4,145 Added 591.3%	4,846 $1.71 Million
Q2 2018 Jul 30, 2018	BUY	$257.52 - $306.91 $1.28 Million - $1.53 Million	4,981 New	4,981 $1.45 Million
Q2 2018 Jul 30, 2018	SELL	$257.52 - $306.91 $1.1 Million - $1.31 Million	-4,280 Reduced 85.93%	701 $203,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $2.67 Million - $3.78 Million	-10,267 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $296,872 - $332,519	-965 Reduced 8.59%	10,267 $3.27 Million
Q3 2017 Nov 20, 2017	BUY	$281.15 - $329.69 $2.12 Million - $2.49 Million	7,548 Added 204.89%	11,232 $3.52 Million
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $1.04 Million - $1.21 Million	3,684	3,684 $1.15 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account

Virtu Financial LLC Biogen Inc. Transaction History